In the wake of Achaogen’s bankruptcy, experts discussed ways to ensure new treatments are available to combat drug-resistant bacteria that threaten a post-antibiotic world. Read more in medcitynews.com
Author Archives: biocon
The company Calyxt, just outside St. Paul, Minn., wanted to make a new kind of soybean, with oil that’s a little healthier — more like olive oil. Read more in npr.org
The draft rules mean that anyone who manipulates human genes in adults or embryos is responsible for adverse outcomes. Read more in nature.com
Malaria treatment resistance could be avoided by studying how resistance evolves during drug development, according to a new paper published in Cell Chemical Biology. Read more in crick.ac.uk
Clinical trials see 17% jump year-over-year, with two approvals near and pipelines expanding. Read more in genengnews.com
EMA launches a social media campaign to highlight how the European medicines regulatory network keeps medicines available in Europe safe and effective. Read more in ema.europa.eu
A safety scare has rocked Solid Biosciences’ drive to get its Duchenne muscular dystrophy (DMD) gene therapy program back on track. Read more in fiercebiotech.com
Researchers may have demonstrated a novel way to protect us from some of the world’s deadliest viruses. Read more in sciencemag.org
In a milestone for synthetic biology, colonies of E. coli thrive with DNA constructed from scratch by humans, not nature. Read more in nytimes.com
Scientists have used an experimental therapy that relies on bacteria-infecting viruses collected, in part, through HHMI’s SEA-PHAGES program to fight a Mycobacterium infection in a 15-year-old girl. Read more in sciencedaily.com